Tachibana M - Search Results

1

Characterization and gene expression analysis of novel matched primary and metastatic renal cell carcinoma cell lines.

Ohno Y, Izumi M, Tachibana M, Kawamura T, Yoshioka K, Aoyagi T, Ohori M, Namiki K, Sakamoto N, Nakagami Y, Hatano T, Akimoto S, Nishimura T. Ohno Y, et al. Among authors: tachibana m. Oncol Rep. 2008 Sep;20(3):501-9. Oncol Rep. 2008. PMID: 18695898

2

Effects of a KiSS-1 peptide, a metastasis suppressor gene, on the invasive ability of renal cell carcinoma cells through a modulation of a matrix metalloproteinase 2 expression.

Yoshioka K, Ohno Y, Horiguchi Y, Ozu C, Namiki K, Tachibana M. Yoshioka K, et al. Among authors: tachibana m. Life Sci. 2008 Aug 29;83(9-10):332-8. doi: 10.1016/j.lfs.2008.06.018. Epub 2008 Jul 1. Life Sci. 2008. PMID: 18644390

3

Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma.

Ohno Y, Izumi M, Yoshioka K, Ohori M, Yonou H, Tachibana M. Ohno Y, et al. Among authors: tachibana m. Oncol Rep. 2008 Sep;20(3):511-6. Oncol Rep. 2008. PMID: 18695899

4

[Case of renal cell carcinoma metastasized to iliopsoas muscle].

Satake N, Ohno Y, Yoshioka K, Sakamoto N, Takeuchi H, Tachibana M. Satake N, et al. Among authors: tachibana m. Nihon Hinyokika Gakkai Zasshi. 2009 Mar;100(3):495-9. doi: 10.5980/jpnjurol.100.495. Nihon Hinyokika Gakkai Zasshi. 2009. PMID: 19348189 Review. Japanese.

5

Followup of neutrophil-to-lymphocyte ratio and recurrence of clear cell renal cell carcinoma.

Ohno Y, Nakashima J, Ohori M, Gondo T, Hatano T, Tachibana M. Ohno Y, et al. Among authors: tachibana m. J Urol. 2012 Feb;187(2):411-7. doi: 10.1016/j.juro.2011.10.026. Epub 2011 Dec 15. J Urol. 2012. PMID: 22177153

6

Association of legumain expression pattern with prostate cancer invasiveness and aggressiveness.

Ohno Y, Nakashima J, Izumi M, Ohori M, Hashimoto T, Tachibana M. Ohno Y, et al. Among authors: tachibana m. World J Urol. 2013 Apr;31(2):359-64. doi: 10.1007/s00345-012-0977-z. Epub 2012 Nov 3. World J Urol. 2013. PMID: 23124822

7

Clinical variables for predicting metastatic renal cell carcinoma patients who might not benefit from cytoreductive nephrectomy: neutrophil-to-lymphocyte ratio and performance status.

Ohno Y, Nakashima J, Ohori M, Tanaka A, Hashimoto T, Gondo T, Hatano T, Tachibana M. Ohno Y, et al. Among authors: tachibana m. Int J Clin Oncol. 2014 Feb;19(1):139-45. doi: 10.1007/s10147-012-0514-5. Epub 2013 Jan 9. Int J Clin Oncol. 2014. PMID: 23299279

8

Annexin II represents metastatic potential in clear-cell renal cell carcinoma.

Ohno Y, Izumi M, Kawamura T, Nishimura T, Mukai K, Tachibana M. Ohno Y, et al. Among authors: tachibana m. Br J Cancer. 2009 Jul 21;101(2):287-94. doi: 10.1038/sj.bjc.6605128. Epub 2009 Jun 9. Br J Cancer. 2009. PMID: 19513064 Free PMC article.

9

Clinical implications of preoperative serum total cholesterol in patients with clear cell renal cell carcinoma.

Ohno Y, Nakashima J, Nakagami Y, Gondo T, Ohori M, Hatano T, Tachibana M. Ohno Y, et al. Among authors: tachibana m. Urology. 2014 Jan;83(1):154-8. doi: 10.1016/j.urology.2013.08.052. Epub 2013 Oct 19. Urology. 2014. PMID: 24149106

10

Prostate-specific antigen stimulates osteoprotegerin production and inhibits receptor activator of nuclear factor-kappaB ligand expression by human osteoblasts.

Yonou H, Horiguchi Y, Ohno Y, Namiki K, Yoshioka K, Ohori M, Hatano T, Tachibana M. Yonou H, et al. Among authors: tachibana m. Prostate. 2007 Jun 1;67(8):840-8. doi: 10.1002/pros.20574. Prostate. 2007. PMID: 17394194

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,313 results

Search Page

Filters